These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 15241418

  • 21. Formation of p27-CDK complexes during the human mitotic cell cycle.
    Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A.
    Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
    [Abstract] [Full Text] [Related]

  • 22. Mitoinhibitory effects of the tumor promoter 2-acetylaminofluorene in rat liver: loss of E2F-1 and E2F-3 expression and cdk 2 kinase activity in late G1.
    Ohlson LC, Koroxenidou L, Porsch-Hällström I.
    J Hepatol; 2004 Jun; 40(6):957-62. PubMed ID: 15158336
    [Abstract] [Full Text] [Related]

  • 23. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US, Park SK, Lee YI, Park JG, Lee YI.
    Oncogene; 2000 Jul 13; 19(30):3384-94. PubMed ID: 10918595
    [Abstract] [Full Text] [Related]

  • 24. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ, Yan S, Herr KD, Wenner CE.
    Cancer Res; 1995 Apr 01; 55(7):1413-6. PubMed ID: 7882344
    [Abstract] [Full Text] [Related]

  • 25. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J.
    Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512
    [Abstract] [Full Text] [Related]

  • 26. Smad3 phosphorylation by cyclin-dependent kinases.
    Liu F.
    Cytokine Growth Factor Rev; 2006 Feb 03; 17(1-2):9-17. PubMed ID: 16289004
    [Abstract] [Full Text] [Related]

  • 27. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA, Dubay MM, Sausville EA, Brizuela L, Worland PJ.
    Cancer Res; 1996 Jul 01; 56(13):2973-8. PubMed ID: 8674031
    [Abstract] [Full Text] [Related]

  • 28. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV.
    Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653
    [Abstract] [Full Text] [Related]

  • 29. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K, Järvinen K, Paasinen-Sohns A, Hölttä E.
    Cancer Res; 2000 Sep 15; 60(18):5244-53. PubMed ID: 11016654
    [Abstract] [Full Text] [Related]

  • 30. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF.
    Voit R, Hoffmann M, Grummt I.
    EMBO J; 1999 Apr 01; 18(7):1891-9. PubMed ID: 10202152
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cytokine-induced phosphoinositide 3-kinase activity promotes Cdk2 activation in factor-dependent hematopoietic cells.
    Henry MK, Nimbalkar D, Hohl RJ, Quelle FW.
    Exp Cell Res; 2004 Sep 10; 299(1):257-66. PubMed ID: 15302592
    [Abstract] [Full Text] [Related]

  • 33. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M, Estanyol JM, Serratosa J, Agell N, Bachs O.
    Hepatology; 1999 Feb 10; 29(2):385-95. PubMed ID: 9918914
    [Abstract] [Full Text] [Related]

  • 34. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
    Taipale M, Tiihonen E, Heiskanen A, Laiho M.
    Exp Cell Res; 2000 Aug 25; 259(1):107-16. PubMed ID: 10942583
    [Abstract] [Full Text] [Related]

  • 35. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
    Santilli G, Cervellera MN, Johnson TK, Lewis RE, Iacobelli S, Sala A.
    Oncogene; 2001 Dec 13; 20(57):8167-74. PubMed ID: 11781832
    [Abstract] [Full Text] [Related]

  • 36. Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1.
    Benzeno S, Narla G, Allina J, Cheng GZ, Reeves HL, Banck MS, Odin JA, Diehl JA, Germain D, Friedman SL.
    Cancer Res; 2004 Jun 01; 64(11):3885-91. PubMed ID: 15172998
    [Abstract] [Full Text] [Related]

  • 37. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation.
    Terada Y, Tatsuka M, Jinno S, Okayama H.
    Nature; 1995 Jul 27; 376(6538):358-62. PubMed ID: 7630405
    [Abstract] [Full Text] [Related]

  • 38. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B).
    Feng XH, Liang YY, Liang M, Zhai W, Lin X.
    Mol Cell; 2002 Jan 27; 9(1):133-43. PubMed ID: 11804592
    [Abstract] [Full Text] [Related]

  • 39. RACK1 regulates G1/S progression by suppressing Src kinase activity.
    Mamidipudi V, Zhang J, Lee KC, Cartwright CA.
    Mol Cell Biol; 2004 Aug 27; 24(15):6788-98. PubMed ID: 15254245
    [Abstract] [Full Text] [Related]

  • 40. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
    Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP, Roberts AB.
    J Biol Chem; 2001 Jun 08; 276(23):19945-53. PubMed ID: 11262418
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.